Form D · Biotechnology
RedPath Integrated Pathology, Inc.
Pittsburgh, PA · CIK 0001308149
Offering snapshot reported Apr 9, 2013 · SEC filing
- Reported sold
- $613K Offering amount: $800K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 25, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2013 | Initial | $612,500 | No comparison | 8 | SEC filing |
| Aug 3, 2012 | Initial | $588,218 | No comparison | 10 | SEC filing |
| May 16, 2011 | Initial | $1,600,000 | No comparison | 12 | SEC filing |
| May 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-194722
Convertible Debt
Source: Form D, filed Apr 9, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack David | Director |
| Jack Davis | Director |
| Craig S Heryford | Executive |
| Peter Kleinhenz | Director |
| Brian Murphy | Director |
| Mark Myslinski | Director |
| Dennis Smith | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2515 Liberty Avenue
Pittsburgh, PA, 15222
Pittsburgh, PA, 15222